megestrol acetate has been researched along with Ovarian Neoplasms in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (26.09) | 18.7374 |
1990's | 7 (30.43) | 18.2507 |
2000's | 8 (34.78) | 29.6817 |
2010's | 2 (8.70) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Churchman, M; Dawson, C; Gourley, C; Herrington, CS; Hollis, RL; Mackean, MJ; Nunes, H; Nussey, F; Rye, T; Stanley, B; Towler, JD; Yan, X | 1 |
Buist, MR; Kenter, GG; van der Velden, J; van Driel, WJ; van Lonkhuijzen, LR; van Meurs, HS | 1 |
Deavers, MT; Gershenson, DM; Malpica, A; Parlow, AF; Silva, EG | 1 |
Berman, ML; Geas, FL; Rutgers, JK; Tewari, DS; Tewari, KS | 1 |
Chang, YC; Huang, SY; Jung, SM; Lai, CH; Ng, KK | 1 |
Chang, CL; Chen, CP; Wang, KL; Wu, CC; Yang, YC | 1 |
Tsagarakis, S; Vassiliadi, D | 1 |
Geisler, HE | 2 |
Durant, JR | 1 |
Burger, CW; Greggi, S; Kenemans, P; van der Vange, N; Vermorken, JB | 1 |
Ahlgren, JD; Alt, D; Ellison, NM; Gottlieb, RJ; Laluna, F; Lokich, JJ; Sinclair, PR; Ueno, W; Wampler, GL; Yeung, KY | 1 |
Aalders, JG; Nooy, M; Oliveira, CF; Pecorelli, S; Rotmensz, N; van der Burg, ME; Veenhof, CH; Vermorken, JB | 1 |
Bartlett, JM; Gabra, H; Hawkins, RA; Langdon, SP; Miller, WR; Rabiaz, GJ; Ritchie, AA; Smyth, JF; Tesdale, AL | 1 |
Ball, H; Greenwald, ES; Vogl, S; Wiernik, PH; Young, JA | 1 |
Dewar, JA; Leese, GP; Naing, KK | 1 |
Belinson, J; Kennedy, A; Kulp, B; Markman, M; Peterson, G; Webster, K | 1 |
Linasmita, V; Srisupundit, S; Wilailak, S | 1 |
Hoffmann, O; Oberhoff, C; Schindler, AE; Winkler, UH | 1 |
Hunter, RE; Longcope, C; Reale, FR; Rose, PG | 1 |
Canetta, R; Kelley, S; Nicaise, C; Rozencweig, M; Schacter, L; Smaldone, L | 1 |
Ballon, SC; Brandt, AE; Christman, JE; Ehsan, MN; Evans, TL; Scudder, SA; Sikic, BI; Soriero, OM; Suey, L | 1 |
Badger, G; Belinson, JL; McClure, M | 1 |
2 review(s) available for megestrol acetate and Ovarian Neoplasms
Article | Year |
---|---|
Unusual causes of Cushing's syndrome.
Topics: ACTH Syndrome, Ectopic; Adrenal Gland Neoplasms; Cushing Syndrome; Female; Glucocorticoids; Humans; Liver Neoplasms; Megestrol Acetate; Ovarian Neoplasms; Pituitary Neoplasms; Ritonavir | 2007 |
Megestrol acetate: clinical experience.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Anorexia; Breast Neoplasms; Cachexia; Carcinoma, Renal Cell; Contraceptive Agents, Male; Contraceptives, Oral; Endometrial Hyperplasia; Female; Humans; Kidney Neoplasms; Male; Megestrol; Megestrol Acetate; Melanoma; Middle Aged; Ovarian Neoplasms; Prostatic Hyperplasia; Prostatic Neoplasms; Rabbits; Tamoxifen; Uterine Neoplasms | 1989 |
7 trial(s) available for megestrol acetate and Ovarian Neoplasms
Article | Year |
---|---|
Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Chromosomes, Human, X; Endometrial Neoplasms; Estrogen Receptor alpha; Female; Fertility; Humans; Immunohistochemistry; Megestrol Acetate; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Receptors, Androgen; Receptors, Progesterone; Treatment Failure; X Chromosome Inactivation | 2005 |
Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program.
Topics: Adenocarcinoma; Aminoglutethimide; Carcinoma; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Megestrol; Megestrol Acetate; Ovarian Neoplasms; Palliative Care; Tamoxifen | 1993 |
Phase II study of high-dose megestrol acetate in patients with advanced ovarian carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Thromboembolism | 1994 |
High-dose megestrol acetate in the treatment of patients with ovarian cancer who have undergone previous treatment: Eastern Cooperative Oncology Group Study PD884.
Topics: Adult; Aged; Female; Humans; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Salvage Therapy | 1998 |
Phase I trial of paclitaxel plus megestrol acetate in patients with paclitaxel-refractory ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Paclitaxel | 2000 |
Phase II study of high-dose megestrol acetate in platinum-refractory epithelial ovarian cancer.
Topics: Adult; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Platinum Compounds; Quality of Life; Survival Analysis; Treatment Failure | 2001 |
Randomized trial of megestrol acetate vs. megestrol acetate/tamoxifen for the management of progressive or recurrent epithelial ovarian carcinoma.
Topics: Adult; Carcinoma; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Random Allocation; Tamoxifen | 1987 |
14 other study(ies) available for megestrol acetate and Ovarian Neoplasms
Article | Year |
---|---|
Endocrine treatment of high grade serous ovarian carcinoma; quantification of efficacy and identification of response predictors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; CA-125 Antigen; Cystadenocarcinoma, Serous; Female; Humans; Letrozole; Megestrol Acetate; Membrane Proteins; Middle Aged; Neoplasm Grading; Ovarian Neoplasms; Predictive Value of Tests; Receptors, Estrogen; Retrospective Studies; Tamoxifen | 2019 |
Evaluation of response to hormone therapy in patients with measurable adult granulosa cell tumors of the ovary.
Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Female; Goserelin; Granulosa Cell Tumor; Humans; Letrozole; Megestrol Acetate; Middle Aged; Nitriles; Ovarian Neoplasms; Ovariectomy; Radiotherapy, Adjuvant; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Salpingectomy; Tamoxifen; Triazoles | 2015 |
Calcifications in ovary and endometrium and their neoplasms.
Topics: Animals; Calcinosis; Chorionic Gonadotropin; Clomiphene; Dihydrotestosterone; Endometrial Neoplasms; Endometrium; Estradiol; Estrone; Female; Growth Hormone; Guinea Pigs; Hormones; Megestrol Acetate; Ovarian Neoplasms; Ovary; Prolactin; Tamoxifen; Testosterone | 2003 |
Surgical cytoreduction and hormone therapy of an advanced endometrial stromal sarcoma of the ovary.
Topics: Antineoplastic Agents, Hormonal; Combined Modality Therapy; Endometriosis; Female; Humans; Megestrol Acetate; Middle Aged; Ovarian Diseases; Ovarian Neoplasms; Ovary; Sarcoma, Endometrial Stromal | 2004 |
Ovarian metastasis in a nulliparous woman with endometrial adenocarcinoma failing conservative hormonal treatment.
Topics: Adenocarcinoma; Adult; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Ovarian Neoplasms | 2005 |
Megestrol acetate for the palliation of advanced ovarian carcinoma.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cystadenocarcinoma; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Palliative Care; Time Factors | 1983 |
Hormonal therapy of gynecologic cancers.
Topics: Adenocarcinoma; Adenoma; Antineoplastic Combined Chemotherapy Protocols; Estrogen Antagonists; Female; Humans; Megestrol; Megestrol Acetate; Ovarian Neoplasms; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1983 |
Experience with hormonal therapy in advanced epithelial ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Carcinoma; Estrogen Antagonists; Female; Flutamide; Gonadotropin-Releasing Hormone; Humans; Luteolytic Agents; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Progesterone Congeners; Remission Induction; Survival Rate; Tamoxifen; Triptorelin Pamoate | 1995 |
Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen.
Topics: Animals; Cell Division; Estradiol; Estrogens; Female; Humans; Immunoenzyme Techniques; Male; Megestrol Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
Megestrol acetate therapy and secondary adrenal suppression.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aged; Antineoplastic Agents; Breast Neoplasms; Corticotropin-Releasing Hormone; Cosyntropin; Female; Humans; Hydrocortisone; Hypoaldosteronism; Hypothalamo-Hypophyseal System; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Pituitary-Adrenal System | 1999 |
Hemostatic effects of high-dose megestrol acetate therapy in patients with advanced gynecological cancer.
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation; Breast Neoplasms; Endometrial Neoplasms; Female; Fibrinolysis; Genital Neoplasms, Female; Humans; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Thrombosis | 2001 |
Prognostic significance of estrogen and progesterone receptors in epithelial ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Tamoxifen | 1990 |
High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Carcinoma; Drug Evaluation; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Megestrol; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Tumor Stem Cell Assay | 1986 |
The use of high-dose megestrol acetate in the treatment of ovarian adenocarcinoma.
Topics: Adenocarcinoma; Aged; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone | 1985 |